quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:13:33·6d
ANALYSTRating
Repligen Corporation logo

Rothschild & Co Redburn initiated coverage on Repligen with a new price target

RGEN· Repligen Corporation
Health Care
Original source

Companies

  • RGEN
    Repligen Corporation
    Health Care

Recent analyst ratings

  • Apr 17UpdateRothschild & Co Redburn$160.00
  • Oct 1UpdateHSBC Securities$150.00
  • Sep 22UpdateEvercore ISI$155.00
  • Jul 22UpdateStephens$160.00
  • Jun 24UpdateBarclays$150.00
  • Apr 29UpdateWolfe Research$160.00

Related

  • INSIDER1d
    SEC Form 4 filed by Loeillot Olivier
  • PR1d
    Repligen to Report First Quarter 2026 Financial Results
  • SEC2d
    SEC Form 144 filed by Repligen Corporation
  • PR6d
    Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
  • SEC21d
    SEC Form DEFA14A filed by Repligen Corporation
  • SEC21d
    SEC Form DEF 14A filed by Repligen Corporation
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Repligen Corporation
  • INSIDER31d
    SEC Form 4 filed by Kuriyel Ralf
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022